(Q40928866)

24 September 2017

Immune parameters differentiating active from latent tuberculosis infection in humans (English)

1 reference

24 September 2017

1 reference

Ji Yeon Lee

1

1 reference

24 September 2017

Young Won Jung

2

1 reference

24 September 2017

Ina Jeong

3

1 reference

24 September 2017

Joon-Sung Joh

4

1 reference

24 September 2017

Soo Yeon Sim

5

1 reference

24 September 2017

Boram Choi

6

1 reference

24 September 2017

Hyeon-Gun Jee

7

1 reference

24 September 2017

Dong-Gyun Lim

8

1 reference

24 September 2017

9 October 2015

1 reference

24 September 2017

1 reference

24 September 2017

95

1 reference

24 September 2017

6

1 reference

24 September 2017

758-763

1 reference

The immune response in tuberculosis

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Initiation and regulation of T-cell responses in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Tuberculosis in patients with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

TB or not TB: that is no longer the question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Production of monoclonal antibodies to lipoarabinomannan-B and use in the detection of mycobacterial antigens in sputum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Tuberculosis vaccines: time to think about the next generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Differential induction of apoptosis and necrosis in monocytes from patients with tuberculosis and healthy control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

T-cell immunophenotyping distinguishes active from latent tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Different patterns of cytokines and chemokines combined with IFN-γ production reflect Mycobacterium tuberculosis infection and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Lipid mediator class switching during acute inflammation: signals in resolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2015.08.003

10.1016/J.TUBE.2015.08.003

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference